"The
Report Travel Vaccines Market to 2019 - Hepatitis A, Japanese
Encephalitis and Meningococcal Vaccine Segments to Drive Growth
provides information on pricing, market analysis, shares, forecast,
and company profiles for key industry participants. -
MarketResearchReports.biz"
The
leading business intelligence provider GBI Research has released its
latest research report, entitled “Travel Vaccines Market to 2019 –
Hepatitis A, Japanese Encephalitis and Meningococcal Vaccine Segments
to Drive Growth”. The report provides insights into the vaccines in
the Travel Vaccines market including market forecasts up to 2019. It
provides an in-depth analysis of the travel vaccines, as well as
insights into the Travel Vaccines R&D pipeline. The report
provides in-depth analysis of the unmet needs, drivers and barriers
that affect the global Travel Vaccines market.
The
report analyzes the market for Travel Vaccines in the US, the top
five countries in Europe (the UK, Germany, France, Italy and Spain)
and Japan. In addition, it provides overview of vaccines market in
India, China and Australia including regulatory frameworks and
profiles of the top companies, deals and pipeline analysis. The
report discusses the global pipeline for Travel Vaccines across
various stages of development. The report is built using data and
information sourced from proprietary databases, primary and secondary
research and in-house analysis by GBI Research’s team of industry
experts.
GBI
Research found that the Travel Vaccines market in the top seven
markets was valued at $1,343m in 2012, increasing at a Compound
Annual Growth Rate (CAGR) of 11% during the 2007–2012 historic
period. The market is projected to witness growth of 7.5% during the
2012–2019 forecast period to reach $2,224m. The growth in the
Travel Vaccines market is driven by increased uptake of hepatitis A
vaccines, which is expected to grow at a CAGR of 7% during the
forecast period and reach $423m in 2019 from $264m in 2012.
View Report At
http://www.marketresearchreports.biz/analysis/167890
Scope
- Annualized market data for the Travel Vaccines market from 2007 to 2012, forecast forward to 2019.
- Analysis of the Travel Vaccines market in the leading geographies of the world, which includes the US, the UK, Germany, France, Italy, Spain, and Japan.
- Market characterization of the Travel Vaccines market including market size, cost of vaccination.
- Key drivers and barriers that have a significant impact on the market.
- Coverage of pipeline molecules in various phases of vaccine development.
- Competitive benchmarking of leading companies. Key companies studied in this report are GlaxoSmithKline, Sanofi, Pfizer, Merck and Novartis.
- Key M&A activities and licensing agreements that have taken place between 2009 and up to January 2013 in the global Travel Vaccines market.
Reasons to Buy
- Align your product portfolio to the markets with high growth potential.
- Develop market-entry and market expansion strategies by identifying the potential region and Travel Vaccines market segments poised for strong growth.
- Create a more tailored country strategy through the understanding of key drivers and barriers of the global Travel Vaccines market.
- Develop key strategic initiatives by understanding the key focus areas and top selling products of leading companies.
- Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships
Download
Sample copy of this Report at :
http://www.marketresearchreports.biz/sample/sample/167890
Table
of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Travel Vaccines Market to 2019:
Introduction
2.1 Overview
3 Travel Vaccines Market to 2019:
Overview
3.1 Vaccine-Preventable Diseases
3.1.1 Types of Vaccines
3.2 Regulatory Framework
3.2.1 US
3.2.2 UK
3.2.3 France
3.2.4 Germany
3.2.5 Italy
3.2.6 Spain
3.2.7 Japan
3.3 Vaccine Manufacturing Process
4 Travel Vaccines Market to 2019:
Market Characterization and Forecast
4.1 Revenue Forecast
4.2 Market Share by Vaccine Type
4.3 Market Share by Geography
4.4 Traveling Population
4.5 Drivers
4.5.1 Aging Population and
Increase in Global Tourist Traffic
4.5.2 Novel Vaccine Technologies
4.5.3 New and Novel Vaccines
Launches Targeting High-Risk Populations
4.6 Restraints
4.6.1 Vaccine Supply Shortage
Issues
4.6.2 High Start-up Costs and
Special Technical Expertise Requirements for Vaccine Production
4.6.3 Public Acceptance
4.6.4 Austerity Measures Leading
to a Drop in Healthcare Funding
5 Travel Vaccines Market to 2019:
Hepatitis A Vaccines
5.1 Disease Overview
5.2 Market Forecasts
5.2.1 US
5.2.2 Top Five European Countries
5.2.3 Japan
5.3 Cost of Vaccination
5.3.1 US
5.3.2 Top Five European Countries
5.3.3 Japan
5.4 Pipeline Analysis
5.4.1 Phase III (Inactive)
5.4.2 Preclinical and Discovery
(Inactive)
6 Travel Vaccines Market to 2019:
Hepatitis B Vaccines
6.1 Disease Overview
6.2 Market Forecasts
6.2.1 US
6.2.2 Top Five European Countries
6.2.3 Japan
6.3 Cost of Vaccination
6.3.1 US
6.3.2 Top Five European Countries
6.3.3 Japan
6.4 Pipeline Analysis
6.4.1 Registration and Phase III
6.4.2 Phase II
6.4.3 Phase I
6.4.4 Preclinical and Discovery
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment